T1	Participants 596 637	patients with left systolic heart failure
T2	Participants 729 801	106 patients were randomized 1:1 to sildenafil (n=53) or placebo (n=53).
T3	Participants 802 946	Patients received sildenafil 25 mg twice a day or matching placebo for the first 2 weeks and 50 mg 3 times a week for the remainder of the trial
